Skip to main content
PolicySpeak
← All files
TPI

Takeda Pharmaceuticals International AG

Company · Japan · EU Transparency Register 815176718826-78

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #885 by legislative files engaged — a count of participation, not a measure of influence.

1.8
declared lobbying FTE
self-declared
€1M+
declared costs / yr (floor)
4
EP accreditations
as declared to the register
2015
in the register since

Declares membership of

  • Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe.
  • Takeda is member of EUCOPE (European Confederation of Pharmaceutical Enterpreneurs).
  • Takeda is also member of PPTA Europe, Japanese Business Council in Europe and MedTech Europe.

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Head office
Zurich, Switzerland
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Takeda in PolicySpeak: request access →

Work at Takeda Pharmaceuticals International AG? so we know who speaks for it.

Follow the file Takeda Pharmaceuticals International AG engages with

One email on Tuesdays when a new position is filed on this file, from Takeda Pharmaceuticals International AG or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Takeda Pharmaceuticals International AG filed 1 position on 4 Aug 2026, across 1 of the 326 legislative files tracked here.

What they argued

European Biotech Actfiled 4 Aug 2026source

Takeda welcomes the European Commissions proposal for a European Biotech Act and supports its overall ambition to strengthen Europes biotechnology and life sciences ecosystem. The Biotech Act is a positive and necessary step to reinforce Europes position in innovative biotechnologybased medicines.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Takeda Pharmaceuticals International AG’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.